Lee Lancashire

Publication Activity (10 Years)

Years Active: 2005-2022
Publications (10 Years): 3

Top Topics

Wearable Sensors

Top Venues

Database J. Biol. Databases Curation

Publications

Maryan Zirkle, Kimon Kotronis, Lee Lancashire, Eugene Rakhmatulin, Magali Haas
BRAINCommons: A Research Infrastructure Designed for Accelerated Discovery in Support of Brain Health. AMIA (2022)
Roozbeh Atri, Kevin Urban, Barbara Marebwa, Tanya Simuni, Caroline Tanner, Andrew Siderowf, Mark Frasier, Magali Haas, Lee Lancashire
Deep Learning for Daily Monitoring of Parkinson's Disease Outside the Clinic Using Wearable Sensors. Sensors 22 (18) (2022)
Daniel Domingo-Fernández, Allison Provost, Alpha Tom Kodamullil, Josep Marín-Llaó, Heather Lasseter, Kristophe Diaz, Nikolaos P. Daskalakis, Lee Lancashire, Martin Hofmann-Apitius, Magali Haas
PTSD Biomarker Database: deep dive metadatabase for PTSD biomarkers, visualizations and analysis tools. Database J. Biol. Databases Curation 2019 (2019)
Christophe Lemetre, Lee Lancashire, Robert C. Rees, Graham R. Ball
Artificial Neural Network Based Algorithm for Biomolecular Interactions Modeling. IWANN (1) (2009)
Lee Lancashire, Christophe Lemetre, Graham R. Ball
An introduction to artificial neural networks in bioinformatics - application to complex microarray and mass spectrometry datasets in cancer studies. Briefings Bioinform. 10 (3) (2009)
Lee Lancashire, Robert C. Rees, Graham R. Ball
Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach. Artif. Intell. Medicine 43 (2) (2008)
Lee Lancashire, O. Schmid, H. Shah, Graham R. Ball
Classification of bacterial species from proteomic data using combinatorial approaches incorporating artificial neural networks, cluster analysis and principal components analysis. Bioinform. 21 (10) (2005)
Lee Lancashire, Selma Ugurel, Colin Creaser, Dirk Schadendorf, Robert C. Rees, Graham R. Ball
Utilizing Artificial Neural Networks to Elucidate Serum Biomarker Patterns Which Discriminate Between Clinical Stages in Melanoma. CIBCB (2005)